Company logo

AMPH - Amphastar Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Drug Manufacturers—Specialty & Generic
Rancho Cucamonga, United States
Type: Equity

AMPH price evolution
AMPH
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $189.85 $201.38 $144.53
Short term investments $30.36 $90.61 $114.71
Net receivables $144.98 $131.41 $138.11 $114.94
Inventory $130.32 $122.41 $115.49 $105.83
Total current assets $545.95 $482.64 $555.08 $489.6
Long term investments $9.94 $15.16 $15.21
Property, plant & equipment $327.52 $320.57 $320.39 $315.64
Goodwill & intangible assets $600.85 $607.06 $613.29
Total noncurrent assets $1008.88 $1019.24 $1023.31
Total investments $40.3 $105.77 $129.92
Total assets $1545.18 $1491.52 $1574.32 $1512.91
Current liabilities
Accounts payable $34.09 $131.21 $116.7 $93.37
Deferred revenue
Short long term debt $4.25 $4.37 $4.34
Total current liabilities $159.01 $136.97 $255.17 $225.41
Long term debt $596.45 $616.34 $622.75 $619.3
Total noncurrent liabilities $641.21 $646.79 $648.08
Total debt $620.58 $627.12 $623.64
Total liabilities $817.5 $778.18 $901.96 $873.49
Shareholders' equity
Retained earnings $530.82 $490.39 $452.44 $409.27
Other shareholder equity -$8.82 -$8.83 -$8.77 -$8.48
Total shareholder equity $713.35 $672.36 $639.42
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $144.53 $156.33 $126.59 $94.51
Short term investments $114.71 $21.86 $12.52 $15.18
Net receivables $114.94 $88.97 $78.8 $66
Inventory $105.83 $103.58 $92.81 $96.83
Total current assets $489.6 $378.32 $318.12 $279.68
Long term investments $15.21 $2.41 $3.98
Property, plant & equipment $315.64 $264.57 $271.49 $280.71
Goodwill & intangible assets $613.29 $37.3 $38.87 $40.62
Total noncurrent assets $1023.31 $363.67 $353.41 $351.55
Total investments $129.92 $24.28 $16.5 $15.18
Total assets $1512.91 $741.99 $671.53 $631.24
Current liabilities
Accounts payable $93.37 $20.5 $89.55 $95.5
Deferred revenue
Short long term debt $4.34 $6.05 $5.18 $15.62
Total current liabilities $225.41 $94.86 $103.81 $112.2
Long term debt $619.3 $72.84 $99.48 $51.65
Total noncurrent liabilities $648.08 $118.47 $122.2 $70.31
Total debt $623.64 $102.58 $104.66 $67.27
Total liabilities $873.49 $213.33 $226.01 $182.51
Shareholders' equity
Retained earnings $409.27 $271.72 $180.34 $117.77
Other shareholder equity -$8.48 -$8.62 -$6.76 -$3.72
Total shareholder equity $639.42 $528.66 $445.52 $402.31
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $182.39 $171.84 $178.1
Cost of revenue $87.23 $81.74 $81.97
Gross Profit $95.17 $90.1 $96.14
Operating activities
Research & development $17.65 $17.04 $20.42
Selling, general & administrative $22.3 $25.05 $21.74
Total operating expenses $39.95 $42.09 $42.16
Operating income $55.22 $48.01 $53.98
Income from continuing operations
EBIT $58.85 $55.91 $50.3
Income tax expense $12.29 $4.13 $4.67
Interest expense $8.61 $8.61 $9.46
Net income
Net income $37.95 $43.18 $36.17
Income (for common shares) $37.95 $43.18 $36.17
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $644.39 $498.99 $437.77 $349.85
Cost of revenue $293.27 $250.13 $238.03 $206.51
Gross Profit $351.12 $248.86 $199.74 $143.34
Operating activities
Research & development $73.74 $74.77 $60.93 $67.23
Selling, general & administrative $80.39 $66.59 $68.92 $65.16
Total operating expenses $154.13 $141.36 $129.85 $132.39
Operating income $196.99 $107.5 $69.89 $10.95
Income from continuing operations
EBIT $196.54 $116.71 $83.63 $5.32
Income tax expense $31.83 $23.48 $20.63 $3.54
Interest expense $27.16 $1.85 $0.89 $0.37
Net income
Net income $137.54 $91.39 $62.12 $1.4
Income (for common shares) $137.54 $91.39 $62.12 $1.4
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $37.95 $43.18 $36.17
Operating activities
Depreciation $7.95 $7.8 $7.61
Business acquisitions & disposals -$129
Stock-based compensation $5.78 $7.36 $4.62
Total cash flows from operations $69.11 $55.29 $23.86
Investing activities
Capital expenditures -$6.04 -$8.79 -$9.44
Investments $65.78 $24.99 -$91.93
Total cash flows from investing -$89.25 -$69.9 $15.24 -$103.05
Financing activities
Dividends paid
Sale and purchase of stock -$8.5
Net borrowings -$8.03 $3.73 -$50.64
Total cash flows from financing -$47.11 -$10.72 -$13.58 -$47.08
Effect of exchange rate -$0.18 -$0.02 -$0.1 -$0.24
Change in cash and equivalents $47.82 -$11.53 $56.85 -$126.51
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $137.54 $91.39 $62.12 $1.4
Operating activities
Depreciation $28.95 $27.32 $25.46 $20.49
Business acquisitions & disposals -$506.41
Stock-based compensation $20.24 $17.86 $18.69 $20.5
Total cash flows from operations $183.5 $89.18 $97.99 $57.27
Investing activities
Capital expenditures -$38.17 -$23.61 -$27.46 -$33.85
Investments -$105.93 -$7.79 $1.4 -$1.15
Total cash flows from investing -$649.12 -$32.78 -$28.67 -$36.41
Financing activities
Dividends paid
Sale and purchase of stock -$58.14 -$39.91 -$28.87 -$24.43
Net borrowings $501.26 -$2.19 $30.36 -$0.88
Total cash flows from financing $454.09 -$26.44 -$37.02 -$2.25
Effect of exchange rate -$0.28 -$0.22 -$0.22 $0.35
Change in cash and equivalents -$11.8 $29.75 $32.08 $18.96
Fundamentals
Market cap $1.69B
Enterprise value N/A
Shares outstanding 48.37M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.37
Net debt/EBITDA N/A
Current ratio 3.43
Quick ratio 2.61